Table 3.
Pediatric vaccine co-administration HV with PCV13 and RV1in 5 LHAs in Sicily from 2016–2019. (Note: during 2018 and 2019 both HV vaccines were used, coadministration data are reported independently whit HV administered).
LHA | Year | Co-administration with PCV 13 vaccine by dose (%) |
Co-administration with RV1 vaccine by dose (%) |
|||
---|---|---|---|---|---|---|
1st dose | 2nd dose | 3rd dose | 1st dose | 2nd dose | ||
AG | 2016 | 96.3 | 96.4 | 92.7 | 70.8 | 72 |
2017 | 97.7 | 93.3 | 86.8 | 77 | 76.5 | |
2018 | 95.0 | 94.9 | 93.6 | 79.5 | 78.9 | |
2019 | 92,6 | 92,3 | 90,7 | 80.6 | 78.8 | |
CT | 2016 | 90.2 | 89.1 | 88.6 | 38.4 | 37.1 |
2017 | 91.5 | 90.6 | 89.7 | 41.4 | 40.3 | |
2018 | 92.1 | 91.5 | 90.2 | 51.7 | 50.2 | |
2019 | 92.0 | 90.6 | 88.7 | 52.2 | 51.2 | |
PA | 2016 | 95.3 | 96.2 | 97,1 | 72.2 | 71 |
2017 | 96.2 | 98.5 | 99.1 | 65.2 | 66 | |
2018 | 98.5 | 99.3 | 99.6 | 68.5 | 65.3 | |
2019 | 97.7 | 99.3 | 99.4 | 67.2 | 64.2 | |
RG | 2016 | 91.7 | 90.2 | 91 | 51.9 | 50.5 |
2017 | 98 | 97 | 95 | 51.2 | 50 | |
2018 | 90.1 | 92.0 | 89.0 | 53.1 | 52.1 | |
2019 | 89.1 | 89.2 | 90.3 | 66.2 | 64.6 | |
TP | 2016 | 98 | 97 | 91 | 79.1 | 76.3 |
2017 | 99 | 98.6 | 95.2 | 76.7 | 75.8 | |
2018 | 98.2 | 97.6 | 94.3 | 80.3 | 78.2 | |
2019 | 98.6 | 93 | 89.8 | 82.1 | 80.2 |